Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
Go back to Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 59.38 +1.72 (2.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.66 | 52 Week High | $19.98 | |||
| Open | $58.03 | 52 Week Low | $10.52 | |||
| Day High | $61.79 | P/E | N/A | |||
| Day Low | $56.21 | EPS | $-1.45 | |||
| Volume | 2,784,193 | |||||
| (NASDAQ: SNDX) | Delayed: 17.97 +0.33 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.64 | 52 Week High | $18.03 | |||
| Open | $17.52 | 52 Week Low | $8.97 | |||
| Day High | $18.11 | P/E | N/A | |||
| Day Low | $17.18 | EPS | $0.00 | |||
| Volume | 2,068,736 | |||||
